What is Zevra Therapeutics, Inc.'s FX effect on cash?

Zevra Therapeutics, Inc. (ZVRA) reported FX effect on cash of $233K in Q1 2026.

How has Zevra Therapeutics, Inc.'s FX effect on cash changed year-over-year?

Zevra Therapeutics, Inc.'s FX effect on cash increased by 162.6% year-over-year, from -$372K to $233K.

What is the long-term trend for Zevra Therapeutics, Inc.'s FX effect on cash?

Over 2 years (2022 to 2024), Zevra Therapeutics, Inc.'s FX effect on cash has grown at a 49.2% compound annual growth rate (CAGR), from $204K to $454K.

What does FX effect on cash mean?

The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.

Zevra Therapeutics, Inc. ZVRA FX Effect on Cash

FX Effect on Cash at other companies

BioMarin PharmaceuticalsBMRN

$1.41M+200%

Ultragenyx PharmaceuticalRARE

-$1M-200%

ANI PharmaceuticalsANIP

$156K+153%

PVL

Palvella TherapeuticsPVLA

-$15K-150%

Arrowhead ResearchARWR

$997K+348%

Mirum Pharmaceuticals, Inc.MIRM

-$1.27M-221%

Other financials

Income statement

See full

Revenue$36.2M+77.5%

Gross profit$34.3M+80.1%

Operating income$52.1M+1,073%

Net income$37.9M+1,323%

EPS (diluted)$0.60+1,100%

Balance sheet

See full

Cash & equivalents$95.6M+156%

Total debt$1.1M-98.1%

Total equity$205.8M+402%

Total assets$278.6M+61.3%

Cash flow

See full

Operating cash flow$6.1M+175%

CapEx$35.0K-64.6%

Free cash flow$6.1M+173%

Valuation

See full

Market cap$773.23M+56.4%

Enterprise value$678.78M+30.8%

P/E6.2×—

P/S6.3×-5.9×

Profitability

See full

Gross margin86.1%+7.2pp

Operating margin-103.9%-43.0pp

Net margin101.6%+60.1pp

FCF margin-75%-30.5pp

Returns & leverage

See full

Return on equity100.7%+60.3pp

Debt / equity0×-1.5×

Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s FX effect on cash?: Zevra Therapeutics, Inc. (ZVRA) reported FX effect on cash of $233K in Q1 2026.
How has Zevra Therapeutics, Inc.'s FX effect on cash changed year-over-year?: Zevra Therapeutics, Inc.'s FX effect on cash increased by 162.6% year-over-year, from -$372K to $233K.
What is the long-term trend for Zevra Therapeutics, Inc.'s FX effect on cash?: Over 2 years (2022 to 2024), Zevra Therapeutics, Inc.'s FX effect on cash has grown at a 49.2% compound annual growth rate (CAGR), from $204K to $454K.
What does FX effect on cash mean?: The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.